XML 74 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Oct. 02, 2022
Oct. 03, 2021
Sales by segment of business        
Sales to customers $ 23,791 $ 23,338 $ 71,237 $ 68,971
Percent Change (as a percent) 1.90%   3.30%  
U.S.        
Sales by segment of business        
Sales to customers $ 12,453 11,963 $ 36,064 34,993
Percent Change (as a percent) 4.10%   3.10%  
International        
Sales by segment of business        
Sales to customers $ 11,338 11,375 $ 35,173 33,978
Percent Change (as a percent) (0.30%)   3.50%  
CONSUMER HEALTH (1)        
Sales by segment of business        
Sales to customers $ 3,795 3,812 $ 11,186 11,307
Percent Change (as a percent) (0.40%)   (1.10%)  
CONSUMER HEALTH (1) | U.S.        
Sales by segment of business        
Sales to customers $ 1,659 1,625 $ 4,903 4,987
Percent Change (as a percent) 2.10%   (1.70%)  
CONSUMER HEALTH (1) | International        
Sales by segment of business        
Sales to customers $ 2,136 2,187 $ 6,283 6,320
Percent Change (as a percent) (2.30%)   (0.60%)  
CONSUMER HEALTH (1) | OTC [Member]        
Sales by segment of business        
Sales to customers $ 1,519 1,484 $ 4,462 4,183
Percent Change (as a percent) 2.50%   6.70%  
CONSUMER HEALTH (1) | OTC [Member] | U.S.        
Sales by segment of business        
Sales to customers $ 695 686 $ 2,028 1,960
Percent Change (as a percent) 1.40%   3.50%  
CONSUMER HEALTH (1) | OTC [Member] | International        
Sales by segment of business        
Sales to customers $ 825 798 $ 2,434 2,223
Percent Change (as a percent) 3.40%   9.50%  
CONSUMER HEALTH (1) | Skin Health/Beauty        
Sales by segment of business        
Sales to customers $ 1,126 1,124 $ 3,264 3,457
Percent Change (as a percent) 0.10%   (5.60%)  
CONSUMER HEALTH (1) | Skin Health/Beauty | U.S.        
Sales by segment of business        
Sales to customers $ 591 569 $ 1,764 1,862
Percent Change (as a percent) 3.70%   (5.30%)  
CONSUMER HEALTH (1) | Skin Health/Beauty | International        
Sales by segment of business        
Sales to customers $ 535 555 $ 1,500 1,595
Percent Change (as a percent) (3.60%)   (6.00%)  
CONSUMER HEALTH (1) | Oral Care        
Sales by segment of business        
Sales to customers $ 375 398 $ 1,135 1,240
Percent Change (as a percent) (5.80%)   (8.50%)  
CONSUMER HEALTH (1) | Oral Care | U.S.        
Sales by segment of business        
Sales to customers $ 158 150 $ 471 478
Percent Change (as a percent) 5.20%   (1.50%)  
CONSUMER HEALTH (1) | Oral Care | International        
Sales by segment of business        
Sales to customers $ 217 248 $ 664 762
Percent Change (as a percent) (12.40%)   (12.80%)  
CONSUMER HEALTH (1) | Baby Care        
Sales by segment of business        
Sales to customers $ 375 391 $ 1,105 1,167
Percent Change (as a percent) (4.30%)   (5.40%)  
CONSUMER HEALTH (1) | Baby Care | U.S.        
Sales by segment of business        
Sales to customers $ 91 95 $ 264 288
Percent Change (as a percent) (4.00%)   (8.20%)  
CONSUMER HEALTH (1) | Baby Care | International        
Sales by segment of business        
Sales to customers $ 283 296 $ 840 879
Percent Change (as a percent) (4.50%)   (4.40%)  
CONSUMER HEALTH (1) | Women's Health        
Sales by segment of business        
Sales to customers $ 225 232 $ 684 684
Percent Change (as a percent) (3.00%)   (0.10%)  
CONSUMER HEALTH (1) | Women's Health | U.S.        
Sales by segment of business        
Sales to customers $ 2 3 $ 9 9
Percent Change (as a percent) (22.00%)   (2.80%)  
CONSUMER HEALTH (1) | Women's Health | International        
Sales by segment of business        
Sales to customers $ 222 229 $ 674 675
Percent Change (as a percent) (2.70%)   (0.10%)  
CONSUMER HEALTH (1) | Wound Care/Other        
Sales by segment of business        
Sales to customers $ 176 182 $ 537 575
Percent Change (as a percent) (3.90%)   (6.70%)  
CONSUMER HEALTH (1) | Wound Care/Other | U.S.        
Sales by segment of business        
Sales to customers $ 122 122 $ 366 390
Percent Change (as a percent) (0.20%)   (6.00%)  
CONSUMER HEALTH (1) | Wound Care/Other | International        
Sales by segment of business        
Sales to customers $ 53 61 $ 170 186
Percent Change (as a percent) (11.40%)   (8.20%)  
PHARMACEUTICAL(1)        
Sales by segment of business        
Sales to customers $ 13,214 12,882 $ 39,400 37,463
Percent Change (as a percent) 2.60%   5.20%  
PHARMACEUTICAL(1) | U.S.        
Sales by segment of business        
Sales to customers $ 7,438 7,221 $ 21,229 20,536
Percent Change (as a percent) 3.00%   3.40%  
PHARMACEUTICAL(1) | International        
Sales by segment of business        
Sales to customers $ 5,776 5,661 $ 18,171 16,927
Percent Change (as a percent) 2.00%   7.30%  
PHARMACEUTICAL(1) | Immunology        
Sales by segment of business        
Sales to customers $ 4,287 4,250 $ 12,817 12,395
Percent Change (as a percent) 0.90%   3.40%  
PHARMACEUTICAL(1) | Immunology | U.S.        
Sales by segment of business        
Sales to customers $ 2,876 2,771 $ 8,230 7,932
Percent Change (as a percent) 3.80%   3.80%  
PHARMACEUTICAL(1) | Immunology | International        
Sales by segment of business        
Sales to customers $ 1,411 1,480 $ 4,587 4,464
Percent Change (as a percent) (4.70%)   2.80%  
PHARMACEUTICAL(1) | Immunology | REMICADE        
Sales by segment of business        
Sales to customers $ 558 761 $ 1,868 2,426
Percent Change (as a percent) (26.60%)   (23.00%)  
PHARMACEUTICAL(1) | Immunology | REMICADE | U.S.        
Sales by segment of business        
Sales to customers $ 350 480 $ 1,099 1,508
Percent Change (as a percent) (27.00%)   (27.10%)  
PHARMACEUTICAL(1) | Immunology | REMICADE | U.S. Exports        
Sales by segment of business        
Sales to customers $ 39 47 $ 163 197
Percent Change (as a percent) (16.90%)   (17.20%)  
PHARMACEUTICAL(1) | Immunology | REMICADE | International        
Sales by segment of business        
Sales to customers $ 169 234 $ 606 721
Percent Change (as a percent) (27.80%)   (16.00%)  
PHARMACEUTICAL(1) | Immunology | SIMPONI / SIMPONI ARIA        
Sales by segment of business        
Sales to customers $ 545 571 $ 1,682 1,717
Percent Change (as a percent) (4.60%)   (2.00%)  
PHARMACEUTICAL(1) | Immunology | SIMPONI / SIMPONI ARIA | U.S.        
Sales by segment of business        
Sales to customers $ 298 295 $ 886 840
Percent Change (as a percent) 0.90%   5.40%  
PHARMACEUTICAL(1) | Immunology | SIMPONI / SIMPONI ARIA | International        
Sales by segment of business        
Sales to customers $ 248 276 $ 797 877
Percent Change (as a percent) (10.40%)   (9.20%)  
PHARMACEUTICAL(1) | Immunology | STELARA        
Sales by segment of business        
Sales to customers $ 2,449 2,378 $ 7,336 6,800
Percent Change (as a percent) 3.00%   7.90%  
PHARMACEUTICAL(1) | Immunology | STELARA | U.S.        
Sales by segment of business        
Sales to customers $ 1,655 1,569 $ 4,766 4,396
Percent Change (as a percent) 5.50%   8.40%  
PHARMACEUTICAL(1) | Immunology | STELARA | International        
Sales by segment of business        
Sales to customers $ 794 809 $ 2,571 2,404
Percent Change (as a percent) (1.90%)   6.90%  
PHARMACEUTICAL(1) | Immunology | TREMFYA        
Sales by segment of business        
Sales to customers $ 729 537 $ 1,916 1,434
Percent Change (as a percent) 35.90%   33.60%  
PHARMACEUTICAL(1) | Immunology | TREMFYA | U.S.        
Sales by segment of business        
Sales to customers $ 530 376 $ 1,303 975
Percent Change (as a percent) 40.70%   33.60%  
PHARMACEUTICAL(1) | Immunology | TREMFYA | International        
Sales by segment of business        
Sales to customers $ 200 161 $ 613 459
Percent Change (as a percent) 24.60%   33.70%  
PHARMACEUTICAL(1) | Immunology | OTHER IMMUNOLOGY        
Sales by segment of business        
Sales to customers $ 5 3 $ 14 18
Percent Change (as a percent)     (19.30%)  
PHARMACEUTICAL(1) | Immunology | OTHER IMMUNOLOGY | U.S.        
Sales by segment of business        
Sales to customers 5 3 $ 14 15
Percent Change (as a percent)     (3.50%)  
PHARMACEUTICAL(1) | Immunology | OTHER IMMUNOLOGY | International        
Sales by segment of business        
Sales to customers 0 0 $ 0 3
PHARMACEUTICAL(1) | Infectious Diseases        
Sales by segment of business        
Sales to customers $ 1,295 1,378 $ 3,908 3,394
Percent Change (as a percent) (6.00%)   15.20%  
PHARMACEUTICAL(1) | Infectious Diseases | U.S.        
Sales by segment of business        
Sales to customers $ 390 679 $ 1,266 1,635
Percent Change (as a percent) (42.70%)   (22.60%)  
PHARMACEUTICAL(1) | Infectious Diseases | International        
Sales by segment of business        
Sales to customers $ 905 698 $ 2,642 1,758
Percent Change (as a percent) 29.70%   50.30%  
PHARMACEUTICAL(1) | Infectious Diseases | COVID-19        
Sales by segment of business        
Sales to customers $ 489 502 $ 1,490 766
Percent Change (as a percent) (2.70%)      
PHARMACEUTICAL(1) | Infectious Diseases | COVID-19 | U.S.        
Sales by segment of business        
Sales to customers $ 0 270 $ 120 421
Percent Change (as a percent)     (71.50%)  
PHARMACEUTICAL(1) | Infectious Diseases | COVID-19 | International        
Sales by segment of business        
Sales to customers 489 233 $ 1,370 346
PHARMACEUTICAL(1) | Infectious Diseases | EDURANT / rilpivirine        
Sales by segment of business        
Sales to customers $ 245 259 $ 718 764
Percent Change (as a percent) (5.20%)   (6.10%)  
PHARMACEUTICAL(1) | Infectious Diseases | EDURANT / rilpivirine | U.S.        
Sales by segment of business        
Sales to customers $ 9 12 $ 27 31
Percent Change (as a percent) (27.10%)   (14.50%)  
PHARMACEUTICAL(1) | Infectious Diseases | EDURANT / rilpivirine | International        
Sales by segment of business        
Sales to customers $ 237 247 $ 691 733
Percent Change (as a percent) (4.20%)   (5.70%)  
PHARMACEUTICAL(1) | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA        
Sales by segment of business        
Sales to customers $ 485 517 $ 1,450 1,568
Percent Change (as a percent) (6.40%)   (7.50%)  
PHARMACEUTICAL(1) | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.        
Sales by segment of business        
Sales to customers $ 372 380 $ 1,096 1,128
Percent Change (as a percent) (2.20%)   (2.90%)  
PHARMACEUTICAL(1) | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International        
Sales by segment of business        
Sales to customers $ 112 137 $ 354 440
Percent Change (as a percent) (17.90%)   (19.50%)  
PHARMACEUTICAL(1) | Infectious Diseases | OTHER INFECTIOUS DISEASES(        
Sales by segment of business        
Sales to customers $ 77 99 $ 251 295
Percent Change (as a percent) (22.40%)   (14.80%)  
PHARMACEUTICAL(1) | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.        
Sales by segment of business        
Sales to customers $ 10 18 $ 24 55
Percent Change (as a percent) (46.40%)   (57.20%)  
PHARMACEUTICAL(1) | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International        
Sales by segment of business        
Sales to customers $ 68 82 $ 228 240
Percent Change (as a percent) (17.10%)   (5.00%)  
PHARMACEUTICAL(1) | Neuroscience        
Sales by segment of business        
Sales to customers $ 1,681 1,680 $ 5,156 5,199
Percent Change (as a percent) 0.00%   (0.80%)  
PHARMACEUTICAL(1) | Neuroscience | U.S.        
Sales by segment of business        
Sales to customers $ 919 835 $ 2,658 2,448
Percent Change (as a percent) 10.00%   8.60%  
PHARMACEUTICAL(1) | Neuroscience | International        
Sales by segment of business        
Sales to customers $ 763 845 $ 2,498 2,751
Percent Change (as a percent) (9.90%)   (9.20%)  
PHARMACEUTICAL(1) | Neuroscience | CONCERTA / methylphenidate        
Sales by segment of business        
Sales to customers $ 158 157 $ 476 489
Percent Change (as a percent) 0.80%   (2.50%)  
PHARMACEUTICAL(1) | Neuroscience | CONCERTA / methylphenidate | U.S.        
Sales by segment of business        
Sales to customers $ 41 35 $ 114 117
Percent Change (as a percent) 19.30%   (2.20%)  
PHARMACEUTICAL(1) | Neuroscience | CONCERTA / methylphenidate | International        
Sales by segment of business        
Sales to customers $ 117 122 $ 362 372
Percent Change (as a percent) (4.40%)   (2.60%)  
PHARMACEUTICAL(1) | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA        
Sales by segment of business        
Sales to customers $ 1,031 1,004 $ 3,132 2,994
Percent Change (as a percent) 2.60%   4.60%  
PHARMACEUTICAL(1) | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.        
Sales by segment of business        
Sales to customers $ 684 648 $ 2,036 1,882
Percent Change (as a percent) 5.30%   8.10%  
PHARMACEUTICAL(1) | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International        
Sales by segment of business        
Sales to customers $ 348 355 $ 1,097 1,111
Percent Change (as a percent) (2.30%)   (1.30%)  
PHARMACEUTICAL(1) | Neuroscience | RISPERDAL CONSTA        
Sales by segment of business        
Sales to customers $ 119 140 $ 373 452
Percent Change (as a percent) (14.90%)   (17.40%)  
PHARMACEUTICAL(1) | Neuroscience | RISPERDAL CONSTA | U.S.        
Sales by segment of business        
Sales to customers $ 67 71 $ 195 210
Percent Change (as a percent) (6.10%)   (7.10%)  
PHARMACEUTICAL(1) | Neuroscience | RISPERDAL CONSTA | International        
Sales by segment of business        
Sales to customers $ 52 69 $ 178 242
Percent Change (as a percent) (24.20%)   (26.30%)  
PHARMACEUTICAL(1) | Neuroscience | OTHER NEUROSCIENCE        
Sales by segment of business        
Sales to customers $ 374 379 $ 1,174 1,265
Percent Change (as a percent) (1.90%)   (7.30%)  
PHARMACEUTICAL(1) | Neuroscience | OTHER NEUROSCIENCE | U.S.        
Sales by segment of business        
Sales to customers $ 127 81 $ 313 239
Percent Change (as a percent) 57.20%   31.10%  
PHARMACEUTICAL(1) | Neuroscience | OTHER NEUROSCIENCE | International        
Sales by segment of business        
Sales to customers $ 246 298 $ 861 1,026
Percent Change (as a percent) (17.90%)   (16.20%)  
PHARMACEUTICAL(1) | Oncology        
Sales by segment of business        
Sales to customers $ 4,064 3,665 $ 12,056 10,770
Percent Change (as a percent) 10.90%   11.90%  
PHARMACEUTICAL(1) | Oncology | U.S.        
Sales by segment of business        
Sales to customers $ 1,812 1,525 $ 5,073 4,364
Percent Change (as a percent) 18.80%   16.20%  
PHARMACEUTICAL(1) | Oncology | International        
Sales by segment of business        
Sales to customers $ 2,252 2,140 $ 6,983 6,406
Percent Change (as a percent) 5.20%   9.00%  
PHARMACEUTICAL(1) | Oncology | DARZALEX        
Sales by segment of business        
Sales to customers $ 2,052 1,580 $ 5,894 4,378
Percent Change (as a percent) 29.80%   34.60%  
PHARMACEUTICAL(1) | Oncology | DARZALEX | U.S.        
Sales by segment of business        
Sales to customers $ 1,097 841 $ 3,071 2,302
Percent Change (as a percent) 30.30%   33.40%  
PHARMACEUTICAL(1) | Oncology | DARZALEX | International        
Sales by segment of business        
Sales to customers $ 955 739 $ 2,823 2,076
Percent Change (as a percent) 29.30%   36.00%  
PHARMACEUTICAL(1) | Oncology | ERLEADA        
Sales by segment of business        
Sales to customers $ 490 344 $ 1,340 907
Percent Change (as a percent) 42.20%   47.70%  
PHARMACEUTICAL(1) | Oncology | ERLEADA | U.S.        
Sales by segment of business        
Sales to customers $ 254 214 $ 693 578
Percent Change (as a percent) 19.10%   20.00%  
PHARMACEUTICAL(1) | Oncology | ERLEADA | International        
Sales by segment of business        
Sales to customers $ 235 130 $ 647 329
PHARMACEUTICAL(1) | Oncology | IMBRUVICA        
Sales by segment of business        
Sales to customers $ 911 1,066 $ 2,918 3,307
Percent Change (as a percent) (14.60%)   (11.80%)  
PHARMACEUTICAL(1) | Oncology | IMBRUVICA | U.S.        
Sales by segment of business        
Sales to customers $ 353 413 $ 1,072 1,311
Percent Change (as a percent) (14.60%)   (18.30%)  
PHARMACEUTICAL(1) | Oncology | IMBRUVICA | International        
Sales by segment of business        
Sales to customers $ 559 654 $ 1,847 1,996
Percent Change (as a percent) (14.60%)   (7.50%)  
PHARMACEUTICAL(1) | Oncology | ZYTIGA / abiraterone acetate        
Sales by segment of business        
Sales to customers $ 456 548 $ 1,500 1,749
Percent Change (as a percent) (16.70%)   (14.20%)  
PHARMACEUTICAL(1) | Oncology | ZYTIGA / abiraterone acetate | U.S.        
Sales by segment of business        
Sales to customers $ 16 25 $ 54 96
Percent Change (as a percent) (33.10%)   (43.40%)  
PHARMACEUTICAL(1) | Oncology | ZYTIGA / abiraterone acetate | International        
Sales by segment of business        
Sales to customers $ 440 523 $ 1,446 1,653
Percent Change (as a percent) (15.90%)   (12.50%)  
PHARMACEUTICAL(1) | Oncology | OTHER ONCOLOGY        
Sales by segment of business        
Sales to customers $ 155 126 $ 403 428
Percent Change (as a percent) 23.10%   (5.90%)  
PHARMACEUTICAL(1) | Oncology | OTHER ONCOLOGY | U.S.        
Sales by segment of business        
Sales to customers $ 92 32 $ 183 76
PHARMACEUTICAL(1) | Oncology | OTHER ONCOLOGY | International        
Sales by segment of business        
Sales to customers $ 64 94 $ 220 352
Percent Change (as a percent) (32.10%)   (37.50%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension        
Sales by segment of business        
Sales to customers $ 852 868 $ 2,547 2,599
Percent Change (as a percent) (1.90%)   (2.00%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | U.S.        
Sales by segment of business        
Sales to customers $ 604 610 $ 1,736 1,778
Percent Change (as a percent) (1.10%)   (2.40%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | International        
Sales by segment of business        
Sales to customers $ 247 258 $ 810 821
Percent Change (as a percent) (3.80%)   (1.30%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | OPSUMIT        
Sales by segment of business        
Sales to customers $ 441 458 $ 1,322 1,371
Percent Change (as a percent) (3.90%)   (3.60%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | OPSUMIT | U.S.        
Sales by segment of business        
Sales to customers $ 289 299 $ 827 861
Percent Change (as a percent) (3.40%)   (4.00%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | OPSUMIT | International        
Sales by segment of business        
Sales to customers $ 152 159 $ 495 510
Percent Change (as a percent) (4.70%)   (3.00%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | UPTRAVI        
Sales by segment of business        
Sales to customers $ 333 309 $ 986 927
Percent Change (as a percent) 7.70%   6.30%  
PHARMACEUTICAL(1) | Pulmonary Hypertension | UPTRAVI | U.S.        
Sales by segment of business        
Sales to customers $ 283 265 $ 824 792
Percent Change (as a percent) 6.60%   3.90%  
PHARMACEUTICAL(1) | Pulmonary Hypertension | UPTRAVI | International        
Sales by segment of business        
Sales to customers $ 50 44 $ 162 135
Percent Change (as a percent) 14.20%   20.40%  
PHARMACEUTICAL(1) | Pulmonary Hypertension | Other        
Sales by segment of business        
Sales to customers $ 78 101 $ 239 301
Percent Change (as a percent) (22.10%)   (20.50%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | Other | U.S.        
Sales by segment of business        
Sales to customers $ 33 47 $ 86 125
Percent Change (as a percent) (29.50%)   (31.30%)  
PHARMACEUTICAL(1) | Pulmonary Hypertension | Other | International        
Sales by segment of business        
Sales to customers $ 46 54 $ 154 176
Percent Change (as a percent) (15.70%)   (13.00%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other        
Sales by segment of business        
Sales to customers $ 1,034 1,041 $ 2,916 3,106
Percent Change (as a percent) (0.60%)   (6.10%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | U.S.        
Sales by segment of business        
Sales to customers $ 837 800 $ 2,266 2,379
Percent Change (as a percent) 4.50%   (4.80%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | International        
Sales by segment of business        
Sales to customers $ 198 241 $ 651 727
Percent Change (as a percent) (17.50%)   (10.40%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | XARELTO        
Sales by segment of business        
Sales to customers $ 689 636 $ 1,806 1,794
Percent Change (as a percent) 8.40%   0.70%  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | XARELTO | U.S.        
Sales by segment of business        
Sales to customers $ 689 636 $ 1,806 1,794
Percent Change (as a percent) 8.40%   0.70%  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | XARELTO | International        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | INVOKANA / INVOKAMET        
Sales by segment of business        
Sales to customers $ 109 133 $ 357 443
Percent Change (as a percent) (18.40%)   (19.50%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | INVOKANA / INVOKAMET | U.S.        
Sales by segment of business        
Sales to customers $ 49 66 $ 164 249
Percent Change (as a percent) (25.80%)   (34.10%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | INVOKANA / INVOKAMET | International        
Sales by segment of business        
Sales to customers $ 60 67 $ 193 194
Percent Change (as a percent) (11.00%)   (0.60%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | Other        
Sales by segment of business        
Sales to customers $ 236 271 $ 753 869
Percent Change (as a percent) (12.80%)   (13.30%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | Other | U.S.        
Sales by segment of business        
Sales to customers $ 98 98 $ 295 336
Percent Change (as a percent) (0.10%)   (12.20%)  
PHARMACEUTICAL(1) | Cardiovascular / Metabolism / Other | Other | International        
Sales by segment of business        
Sales to customers $ 138 173 $ 458 533
Percent Change (as a percent) (20.00%)   (14.00%)  
MEDTECH(3)        
Sales by segment of business        
Sales to customers $ 6,782 6,644 $ 20,651 20,201
Percent Change (as a percent) 2.10%   2.20%  
MEDTECH(3) | U.S.        
Sales by segment of business        
Sales to customers $ 3,356 3,117 $ 9,932 9,470
Percent Change (as a percent) 7.70%   4.90%  
MEDTECH(3) | International        
Sales by segment of business        
Sales to customers $ 3,426 3,527 $ 10,719 10,731
Percent Change (as a percent) (2.90%)   (0.10%)  
MEDTECH(3) | Interventional Solutions        
Sales by segment of business        
Sales to customers $ 1,060 957 $ 3,202 2,952
Percent Change (as a percent) 10.80%   8.50%  
MEDTECH(3) | Interventional Solutions | U.S.        
Sales by segment of business        
Sales to customers $ 547 444 $ 1,566 1,353
Percent Change (as a percent) 23.20%   15.70%  
MEDTECH(3) | Interventional Solutions | International        
Sales by segment of business        
Sales to customers $ 513 513 $ 1,636 1,599
Percent Change (as a percent) 0.00%   2.30%  
MEDTECH(3) | Orthopaedics        
Sales by segment of business        
Sales to customers $ 2,095 2,093 $ 6,440 6,433
Percent Change (as a percent) 0.10%   0.10%  
MEDTECH(3) | Orthopaedics | U.S.        
Sales by segment of business        
Sales to customers $ 1,309 1,249 $ 3,936 3,821
Percent Change (as a percent) 4.80%   3.00%  
MEDTECH(3) | Orthopaedics | International        
Sales by segment of business        
Sales to customers $ 785 843 $ 2,504 2,611
Percent Change (as a percent) (6.90%)   (4.10%)  
MEDTECH(3) | Orthopaedics | HIPS        
Sales by segment of business        
Sales to customers $ 352 355 $ 1,129 1,102
Percent Change (as a percent) (0.90%)   2.50%  
MEDTECH(3) | Orthopaedics | HIPS | U.S.        
Sales by segment of business        
Sales to customers $ 228 209 $ 693 651
Percent Change (as a percent) 9.10%   6.50%  
MEDTECH(3) | Orthopaedics | HIPS | International        
Sales by segment of business        
Sales to customers $ 124 146 $ 437 451
Percent Change (as a percent) (15.10%)   (3.30%)  
MEDTECH(3) | Orthopaedics | KNEES        
Sales by segment of business        
Sales to customers $ 317 316 $ 1,005 983
Percent Change (as a percent) 0.40%   2.30%  
MEDTECH(3) | Orthopaedics | KNEES | U.S.        
Sales by segment of business        
Sales to customers $ 203 184 $ 620 579
Percent Change (as a percent) 9.80%   6.90%  
MEDTECH(3) | Orthopaedics | KNEES | International        
Sales by segment of business        
Sales to customers $ 115 131 $ 386 403
Percent Change (as a percent) (12.80%)   (4.40%)  
MEDTECH(3) | Orthopaedics | TRAUMA        
Sales by segment of business        
Sales to customers $ 717 715 $ 2,161 2,157
Percent Change (as a percent) 0.20%   0.20%  
MEDTECH(3) | Orthopaedics | TRAUMA | U.S.        
Sales by segment of business        
Sales to customers $ 473 455 $ 1,412 1,352
Percent Change (as a percent) 3.80%   4.40%  
MEDTECH(3) | Orthopaedics | TRAUMA | International        
Sales by segment of business        
Sales to customers $ 244 260 $ 749 805
Percent Change (as a percent) (6.00%)   (7.00%)  
MEDTECH(3) | Orthopaedics | SPINE, SPORTS & OTHER        
Sales by segment of business        
Sales to customers $ 708 706 $ 2,144 2,190
Percent Change (as a percent) 0.30%   (2.10%)  
MEDTECH(3) | Orthopaedics | SPINE, SPORTS & OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 406 401 $ 1,211 1,239
Percent Change (as a percent) 1.30%   (2.20%)  
MEDTECH(3) | Orthopaedics | SPINE, SPORTS & OTHER | International        
Sales by segment of business        
Sales to customers $ 303 306 $ 933 952
Percent Change (as a percent) (1.10%)   (2.00%)  
MEDTECH(3) | Surgery        
Sales by segment of business        
Sales to customers $ 2,422 2,405 $ 7,306 7,299
Percent Change (as a percent) 0.70%   0.10%  
MEDTECH(3) | Surgery | U.S.        
Sales by segment of business        
Sales to customers $ 984 948 $ 2,897 2,881
Percent Change (as a percent) 3.70%   0.50%  
MEDTECH(3) | Surgery | International        
Sales by segment of business        
Sales to customers $ 1,439 1,457 $ 4,410 4,418
Percent Change (as a percent) (1.20%)   (0.20%)  
MEDTECH(3) | Surgery | ADVANCED        
Sales by segment of business        
Sales to customers $ 1,158 1,144 $ 3,460 3,430
Percent Change (as a percent) 1.20%   0.90%  
MEDTECH(3) | Surgery | ADVANCED | U.S.        
Sales by segment of business        
Sales to customers $ 457 440 $ 1,328 1,304
Percent Change (as a percent) 3.80%   1.80%  
MEDTECH(3) | Surgery | ADVANCED | International        
Sales by segment of business        
Sales to customers $ 701 705 $ 2,132 2,126
Percent Change (as a percent) (0.40%)   0.30%  
MEDTECH(3) | Surgery | GENERAL        
Sales by segment of business        
Sales to customers $ 1,264 1,261 $ 3,846 3,869
Percent Change (as a percent) 0.30%   (0.60%)  
MEDTECH(3) | Surgery | GENERAL | U.S.        
Sales by segment of business        
Sales to customers $ 527 508 $ 1,569 1,577
Percent Change (as a percent) 3.60%   (0.50%)  
MEDTECH(3) | Surgery | GENERAL | International        
Sales by segment of business        
Sales to customers $ 737 752 $ 2,277 2,292
Percent Change (as a percent) (2.00%)   (0.60%)  
MEDTECH(3) | Vision        
Sales by segment of business        
Sales to customers $ 1,206 1,189 $ 3,704 3,517
Percent Change (as a percent) 1.40%   5.30%  
MEDTECH(3) | Vision | U.S.        
Sales by segment of business        
Sales to customers $ 517 475 $ 1,534 1,414
Percent Change (as a percent) 8.80%   8.50%  
MEDTECH(3) | Vision | International        
Sales by segment of business        
Sales to customers $ 689 714 $ 2,170 2,103
Percent Change (as a percent) (3.50%)   3.20%  
MEDTECH(3) | Vision | CONTACT LENSES / OTHER        
Sales by segment of business        
Sales to customers $ 908 882 $ 2,712 2,607
Percent Change (as a percent) 3.00%   4.00%  
MEDTECH(3) | Vision | CONTACT LENSES / OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 405 359 $ 1,179 1,082
Percent Change (as a percent) 12.60%   9.00%  
MEDTECH(3) | Vision | CONTACT LENSES / OTHER | International        
Sales by segment of business        
Sales to customers $ 503 522 $ 1,533 1,525
Percent Change (as a percent) (3.60%)   0.50%  
MEDTECH(3) | Vision | SURGICAL        
Sales by segment of business        
Sales to customers $ 298 308 $ 992 910
Percent Change (as a percent) (3.20%)   9.00%  
MEDTECH(3) | Vision | SURGICAL | U.S.        
Sales by segment of business        
Sales to customers $ 112 117 $ 355 333
Percent Change (as a percent) (3.20%)   6.80%  
MEDTECH(3) | Vision | SURGICAL | International        
Sales by segment of business        
Sales to customers $ 186 191 $ 637 577
Percent Change (as a percent) (3.30%)   10.30%  
CONSUMER HEALTH and PHARMACEUTICAL [Member] | OTC [Member] | CHINA        
Sales by segment of business        
Sales to customers   $ 100   $ 300